News

Advanced Prostate Cancer Slows With New Drug

Advanced Prostate Cancer Slows With New Drug

June 4, 2012

A new medication proved effective in slowing the spread of metastatic prostate cancer, while helping to maintain the quality of life, in patients with advanced disease. The phase 3 study was unblinded midway, allowing patients receiving the placebo to instead take the drug because of the favorable results.

Cancer Drugs: Better, Cheaper

Cancer Drugs: Better, Cheaper

June 1, 2012

Cancer drug development is known to be too slow, costly and fraught with failure. Now the U.S. Food and Drug Administration is issuing recommendations for breast cancer trials that would substantially accelerate patient access to new medications while lowering the time and cost of drug development.

Medical Student Confronts Cancer at Bench, Bedside and Beyond: Sam Brondfield

Medical Student Confronts Cancer at Bench, Bedside and Beyond: Sam Brondfield

May 30, 2012

At one of the highest-ranked medical schools in the country, it’s not surprising to find students with big appetites for learning. In the laboratory, there are those who seek out challenges at the bench, peering into microscopes for answers.

UCSF Clinicians Get New Ammunition in Fight Against Childhood Cancers

UCSF Clinicians Get New Ammunition in Fight Against Childhood Cancers

May 4, 2012

It’s a real challenge to treat a patient with relapsed cancer, because the cancer has outsmarted initial treatment and has become more resistant, says Steven DuBois, MD, assistant professor of pediatrics at UCSF’s School of Medicine and a specialist in childhood cancers.

'Thin Red Line' Around Breast Cancer

'Thin Red Line' Around Breast Cancer

May 2, 2012

A pioneering approach to imaging breast cancer in mice has revealed new clues about why the human immune system often fails to attack tumors and keep cancer in check. This observation, by scientists at the University of California, San Francisco (UCSF), may help to reveal new approaches to cancer immunotherapy.

image

Health, Prognosis Not Taken Into Account When Treating Older Lung Cancer Patients, Study Finds

May 1, 2012

In a study of patients 65 and older with non-small-cell lung cancer (NSCLC), younger patients were more likely to receive treatment than older patients, regardless of overall health and prognosis.